Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Novo Nordisk
Novo Nordisk is a leading global pharmaceutical company from Denmark, focusing on developing innovative therapies. Its primary areas of expertise are diabetes and obesity, while rare blood disorders and hormone-related conditions are also core business segments. The company is dedicated to improving patient health and quality of life worldwide through advanced medicines.
Recap: the latest results
Novo Nordisk (NOVO B) reported its Q2 2026 results on August 4, 2026, before the market open. The company reported earnings per share (EPS) of 6.18 DKK, beating the analyst estimate of 5.03 DKK by 22.9%. Revenue reached 78,488 million DKK. Following the release, the stock price rose by 1.75%.
Generated automatically from our data — as of 08/12/2026 Read the article →
Frequently asked questions
When will Novo Nordisk report its next quarterly earnings?
Novo Nordisk is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Novo Nordisk last report quarterly earnings?
Novo Nordisk last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at 6.18 DKK.
How does Novo Nordisk stock react to earnings?
Across its last 5 earnings reports, Novo Nordisk stock moved by ±2.9% on average the following day. The largest reaction was +4.5% on 02/05/2025; 3 of 5 reactions were positive.
How often has Novo Nordisk beaten expectations?
Novo Nordisk has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Novo Nordisk earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.9%
Avg. next-day move
+4.5%
Largest move (02/05/2025)
60%
Share of positive reactions
±5%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
+7.3%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Novo Nordisk
Country
🇩🇰
More Financial Information